口服氘代二十二碳六烯酸对慢性氧化应激小鼠模型RPE变性的保护作用
该研究在肝特异性铁调素及铜蓝蛋白/铁调素敲除小鼠中评估口服氘代DHA(D-DHA)对RPE变性的保护作用,并评估长期给药的安全性。结果显示D-DHA可显著预防或阻止RPE损伤,野生型小鼠长期给药无视网膜异常,但宫内起始给药至12月龄出现轻微ERG振幅及Rpe65表达缺陷。提示DHA氧化是视网膜铁毒性的关键机制。
要点
- 口服D-DHA可显著预防或阻止铁代谢相关KO小鼠的RPE自发光斑块损伤。
- 野生型小鼠从3月龄至15月龄持续D-DHA饮食未出现视网膜异常。
- 宫内起始D-DHA至12月龄出现轻微ERG振幅及Rpe65表达缺陷。
核心结论
- 口服D-DHA对RPE铁死亡有强保护作用且副作用极小。
- DHA氧化是视网膜铁毒性的关键机制,支持D-DHA在视网膜氧化应激疾病中的临床潜力。
研究设计与样本
- 肝特异性Hepc及Cp/Hepc敲除小鼠在疾病不同阶段喂食含0.25% D-DHA或含正常H-DHA的对照饮食。
- 采用SLO活体成像和组织学评估RPE损伤。
- 安全性研究:野生型小鼠从宫内或3月龄开始喂食实验饮食持续12个月,评估SLO、OCT、TEM、ERG和qPCR。
主要发现
- KO小鼠喂食对照饮食后出现扩大的自发光斑块和肥厚RPE细胞。
- D-DHA饮食根据起始年龄显著预防或阻止上述损伤。
- 野生型小鼠3至15月龄D-DHA饮食未出现视网膜异常。
- 宫内起始D-DHA的小鼠视网膜发育和结构正常,但至12月龄出现轻微ERG振幅和Rpe65表达缺陷。
临床怎么用
- D-DHA可能作为涉及视网膜氧化应激疾病(如干性AMD)的潜在口服干预,但需注意宫内暴露可能影响视网膜功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oxidative stress is associated with many retinal diseases, including age-related macular degeneration (AMD). The purpose of this study is to investigate the efficacy of oral deuterated docosahexaenoic acid (D-DHA), an oxidation-resistant lipid, in a mouse model with features of dry AMD. We also evaluated whether long-term D-DHA dosing affects normal retinal structure or function. METHODS: Liver-specific hepcidin (Hepc) and ceruloplasmin/hepcidin (Cp/Hepc) knock-out (KO) mice were fed experimental diet containing 0.25% D-DHA or control containing normal H-DHA during various stages of disease progression. Retinal pigment epithelium (RPE) damage was assessed with in vivo scanning laser ophthalmoscopy (SLO) imaging and histology. For the safety study, wild-type mice were fed the diets beginning in utero or at 3 months of age, continuing for 12 months. These mice were analyzed to assess retinal structure (SLO, optical coherence tomography [OCT], and transmission electron microscopy [TEM]), function (ERG), and gene expression (qPCR). RESULTS: KO mice fed control diet developed expanding autofluorescent patches of hypertrophic RPE cells. This damage was markedly prevented or halted by diet with D-DHA, depending on age at diet onset. Wild-type mice administered diet with D-DHA from age 3 to 15 months had no retinal abnormalities. Mice administered D-DHA beginning in utero had normal retinal development and structure but minor deficits in ERG amplitudes and Rpe65 expression by age 12 months. CONCLUSIONS: Oral D-DHA was strongly protective against RPE ferroptosis, with minimal side effects. This study suggests that DHA oxidation is a key mechanism of retinal iron toxicity and supports the potential clinical application of D-DHA for diseases involving retinal oxidative stress.
引用
- Foshe S, Anderson BD, Song Y, et al. Oral Deuterated Docosahexaenoic Acid Protects Against Onset and Progression of RPE Degeneration in a Mouse Model of Chronic Oxidative Stress. Invest Ophthalmol Vis Sci. 2026. PMID: 41979253. doi:10.1167/iovs.67.4.28
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。